Levels of anti-apoptotic Bcl-2 and pro-apoptotic Bax have been shown to correlate with spontaneous apoptosis in AML cells in vitro [10], and the ratio of Bax to Bcl-2 in patient cells is proposed to predict clinical response and outcome [8]. This evidence concerns the gene BCL2 and acute myeloid leukemia.